Literature DB >> 26740110

Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections.

Donald T Gracias1, Alina C Boesteanu1, Joseph A Fraietta2, Jennifer L Hope3, Alison J Carey4, Yvonne M Mueller3, Omkar U Kawalekar5, Adam J Fike1, Carl H June5, Peter D Katsikis6.   

Abstract

The p110δ isoform of PI3K is known to play an important role in immunity, yet its contribution to CTL responses has not been fully elucidated. Using murine p110δ-deficient CD8(+) T cells, we demonstrated a critical role for the p110δ subunit in the generation of optimal primary and memory CD8(+) T cell responses. This was demonstrated in both acute viral and intracellular bacterial infections in mice. We show that p110δ signaling is required for CD8(+) T cell activation, proliferation and effector cytokine production. We provide evidence that the effects of p110δ signaling are mediated via Akt activation and through the regulation of TCR-activated oxidative phosphorylation and aerobic glycolysis. In light of recent clinical trials that employ drugs targeting p110δ in certain cancers and other diseases, our study suggests caution in using these drugs in patients, as they could potentially increase susceptibility to infectious diseases. These studies therefore reveal a novel and direct role for p110δ signaling in in vivo CD8(+) T cell immunity to microbial pathogens.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26740110      PMCID: PMC4761756          DOI: 10.4049/jimmunol.1501890

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch.

Authors:  Patrick M Gubser; Glenn R Bantug; Leyla Razik; Marco Fischer; Sarah Dimeloe; Gideon Hoenger; Bojana Durovic; Annaïse Jauch; Christoph Hess
Journal:  Nat Immunol       Date:  2013-08-18       Impact factor: 25.606

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

4.  The p110 delta isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets.

Authors:  Dong Liu; Jude E Uzonna
Journal:  J Immunol       Date:  2010-02-12       Impact factor: 5.422

5.  Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation.

Authors:  Baher F Nashed; Tingting Zhang; Monther Al-Alwan; Ganesh Srinivasan; Andrew J Halayko; Klaus Okkenhaug; Bart Vanhaesebroeck; Kent T Hayglass; Aaron J Marshall
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

6.  P110delta, a novel phosphoinositide 3-kinase in leukocytes.

Authors:  B Vanhaesebroeck; M J Welham; K Kotani; R Stein; P H Warne; M J Zvelebil; K Higashi; S Volinia; J Downward; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.

Authors:  Dalya R Soond; Elisa Bjørgo; Kristine Moltu; Verity Q Dale; Daniel T Patton; Knut Martin Torgersen; Fiona Galleway; Breda Twomey; Jonathan Clark; J S Hill Gaston; Kjetil Taskén; Peter Bunyard; Klaus Okkenhaug
Journal:  Blood       Date:  2010-01-15       Impact factor: 22.113

8.  Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Daniel T Patton; Oliver A Garden; Wayne P Pearce; Louise E Clough; Clare R Monk; Eva Leung; Wendy C Rowan; Sara Sancho; Lucy S K Walker; Bart Vanhaesebroeck; Klaus Okkenhaug
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

9.  Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.

Authors:  Andrew N Macintyre; David Finlay; Gavin Preston; Linda V Sinclair; Caryll M Waugh; Peter Tamas; Carmen Feijoo; Klaus Okkenhaug; Doreen A Cantrell
Journal:  Immunity       Date:  2011-02-03       Impact factor: 31.745

10.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

View more
  13 in total

1.  PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.

Authors:  Bola S Hanna; Philipp M Roessner; Annika Scheffold; Billy M C Jebaraj; Yasmin Demerdash; Selcen Öztürk; Peter Lichter; Stephan Stilgenbauer; Martina Seiffert
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

2.  A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.

Authors:  S Elizabeth Franks; Andrew Getahun; John C Cambier
Journal:  J Immunol       Date:  2019-05-10       Impact factor: 5.422

3.  PI3K Isoforms in CD8+ T Cell Development and Function.

Authors:  Pankaj Gaur; Mikayel Mkrtichyan; Vivek Verma; Nazli Jafarzadeh; Mariana Hattar; Seema Gupta; Samir N Khleif
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

4.  PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells.

Authors:  Jacob S Bowers; Kinga Majchrzak; Michelle H Nelson; Bulent Arman Aksoy; Megan M Wyatt; Aubrey S Smith; Stefanie R Bailey; Lillian R Neal; Jeffrey E Hammerbacher; Chrystal M Paulos
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

5.  Exhaustion of the CD8+ T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta.

Authors:  Marjolein W J Wentink; Yvonne M Mueller; Virgil A S H Dalm; Gertjan J Driessen; P Martin van Hagen; Joris M van Montfrans; Mirjam van der Burg; Peter D Katsikis
Journal:  Front Immunol       Date:  2018-03-07       Impact factor: 7.561

6.  The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment.

Authors:  Hanjiao Qin; Linlin Liu; Shu Sun; Dan Zhang; Jiyao Sheng; Bingjin Li; Wei Yang
Journal:  PeerJ       Date:  2018-06-19       Impact factor: 2.984

7.  B cell adaptor for PI3-kinase (BCAP) modulates CD8+ effector and memory T cell differentiation.

Authors:  Mark D Singh; Minjian Ni; Jenna M Sullivan; Jessica A Hamerman; Daniel J Campbell
Journal:  J Exp Med       Date:  2018-08-09       Impact factor: 14.307

Review 8.  Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy.

Authors:  Klaus Okkenhaug; Mariona Graupera; Bart Vanhaesebroeck
Journal:  Cancer Discov       Date:  2016-09-21       Impact factor: 39.397

Review 9.  PI3Kδ and primary immunodeficiencies.

Authors:  Carrie L Lucas; Anita Chandra; Sergey Nejentsev; Alison M Condliffe; Klaus Okkenhaug
Journal:  Nat Rev Immunol       Date:  2016-09-12       Impact factor: 53.106

10.  Hyperactive PI3Kδ predisposes naive T cells to activation via aerobic glycolysis programs.

Authors:  Yanjun Jia; Qiuyun Yang; Yanping Wang; Wenyan Li; Xuemei Chen; Tao Xu; Zhirui Tian; Minxuan Feng; Liang Zhang; Wenjing Tang; Na Tian; Lina Zhou; Wenxia Song; Xiaodong Zhao
Journal:  Cell Mol Immunol       Date:  2020-02-25       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.